Metcela
metcela.com
Actively hiring
Biotechnology
Regenerative Medicine
Cell & Gene Therapy
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Metcela is a Japanese pre-clinical stage biotechnology company developing cell therapies for heart failure. The company is developing a clinically oriented cell therapy product called VCF intended to treat chronic heart failure. It aims to address the increasing burden of heart failure driven by aging and lifestyle diseases by delivering a regenerative alternative to current symptomatic treatments.